BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38411725)

  • 1. Employing Bayesian analysis to establish a cut-off point and assess stigma prevalence in substance use disorder: a comprehensive study of the Chinese version of the Substance Use Stigma Mechanism Scale.
    Wang D; Zhou Y; Chen S; Wu Q; He L; Wang Q; Hao Y; Liu Y; Peng P; Li M; Liu T; Ma Y
    Soc Psychiatry Psychiatr Epidemiol; 2024 Feb; ():. PubMed ID: 38411725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Adaptation of the Substance Use Stigma Mechanism Scale (SU-SMS) Into Turkish: A Validity and Reliability Study.
    Can Gür G; Tanriverdi D; Ariti M; Özgün Öztürk F
    J Am Psychiatr Nurses Assoc; 2022; 28(4):295-305. PubMed ID: 32806988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor structure, internal reliability and construct validity of the Methadone Maintenance Treatment Stigma Mechanisms Scale (MMT-SMS).
    Smith LR; Mittal ML; Wagner K; Copenhaver MM; Cunningham CO; Earnshaw VA
    Addiction; 2020 Feb; 115(2):354-367. PubMed ID: 31478272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substance use stigma: Reliability and validity of a theory-based scale for substance-using populations.
    Smith LR; Earnshaw VA; Copenhaver MM; Cunningham CO
    Drug Alcohol Depend; 2016 May; 162():34-43. PubMed ID: 26972790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substance use stigma mechanisms scale: Factor structure, reliability, and validity in Mexican adults that use drugs.
    Rafful C; López A; Contreras-Valdez JA; Morales M; Jiménez-Rivagorza L; Orozco R
    Drug Alcohol Depend; 2022 Oct; 239():109598. PubMed ID: 35961267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement invariance and psychometric properties of Perceived Stigma toward People who use Substances (PSPS) among three types of substance use disorders: Heroin, amphetamine, and alcohol.
    Chang CC; Chang KC; Hou WL; Yen CF; Lin CY; Potenza MN
    Drug Alcohol Depend; 2020 Nov; 216():108319. PubMed ID: 33027709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factorial validity of a substance-use stigma scale in methamphetamine-using adults in China.
    Chen S; Ma Y; Cai W; Moretta T; Wang X; Liu T; Potenza MN
    Drug Alcohol Depend; 2020 Jan; 206():107677. PubMed ID: 31732296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and examination of the attribution questionnaire-substance use disorder (AQ-SUD) to measure public stigma towards adolescents experiencing substance use disorders.
    Johnson-Kwochka A; Aalsma MC; Monahan PO; Salyers MP
    Drug Alcohol Depend; 2021 Apr; 221():108600. PubMed ID: 33689966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reliability and Validity of the Chinese Version of the Scale for Assessing the Stigma of Mental Illness in Nursing.
    Wang W; Cui H; Zhang W; Xu X; Dong H
    Front Psychiatry; 2021; 12():754774. PubMed ID: 34721117
    [No Abstract]   [Full Text] [Related]  

  • 10. What Is the Optimal Cut-Off Point of the 10-Item Center for Epidemiologic Studies Depression Scale for Screening Depression Among Chinese Individuals Aged 45 and Over? An Exploration Using Latent Profile Analysis.
    Fu H; Si L; Guo R
    Front Psychiatry; 2022; 13():820777. PubMed ID: 35360127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recovery schools for improving behavioral and academic outcomes among students in recovery from substance use disorders: a systematic review.
    Hennessy EA; Tanner-Smith EE; Finch AJ; Sathe N; Kugley S
    Campbell Syst Rev; 2018; 14(1):1-86. PubMed ID: 37131375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perceived stigma among discharged patients of COVID-19 in Wuhan, China: A latent profile analysis.
    Wu Y; Dai Z; Xiao W; Wang H; Huang Y; Si M; Fu J; Chen X; Jia M; Leng Z; Cui D; Mak WWS; Su X
    Front Public Health; 2023; 11():1111900. PubMed ID: 37026126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perceived need for care and stigma experiences among individuals with methamphetamine-related admissions to inpatient mental health wards.
    Wilson L; Karnik N; Wong JY; Barchet L; Sareen J; Jwely A; Nickel N; Konrad G; Nepon J; Bolton JM
    Harm Reduct J; 2023 Aug; 20(1):104. PubMed ID: 37533062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Text Messaging as a Screening Tool for Depression and Related Conditions in Underserved, Predominantly Minority Safety Net Primary Care Patients: Validity Study.
    Jin H; Wu S
    J Med Internet Res; 2020 Mar; 22(3):e17282. PubMed ID: 32213473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stigma and help-seeking: The interplay of substance use and gender and sexual minority identity.
    Benz MB; Palm Reed K; Bishop LS
    Addict Behav; 2019 Oct; 97():63-69. PubMed ID: 31150992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cultural adaptation and psychometric properties of the Substance Abuse Self-Stigma Scale among Latinos with Substance Use Disorders: An effective screening tool for correctional and community settings.
    Pérez-Pedrogo C; Planas-García BY; Ortega-Guzmán J; Rivera-Suazo S; Caraballo JN; Albizu-García CE
    Stigma Health; 2022 Aug; 7(3):347-357. PubMed ID: 35978841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing self-stigma levels and associated factors among substance use disorder patients at two selected psychiatric hospitals in Egypt: a cross-sectional study.
    Elkalla IHR; El-Gilany AH; Baklola M; Terra M; Aboeldahab M; Sayed SE; ElWasify M
    BMC Psychiatry; 2023 Aug; 23(1):592. PubMed ID: 37582741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experiences of and recommendations for LGBTQ+-affirming substance use services: A qualitative study with LGBTQ+ people who use opioids and other drugs.
    Paschen-Wolff MM; DeSousa A; Paine EA; Hughes TL; Campbell ANC
    Res Sq; 2023 Sep; ():. PubMed ID: 37693444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protocol: a cluster randomised control trial study exploring stigmatisation and recovery-based perspectives regarding mental illness and substance use problems among primary healthcare providers across Toronto, Ontario.
    Khenti A; Mann R; Sapag JC; Bobbili SJ; Lentinello EK; Maas MV; Agic B; Hamilton H; Stuart H; Patten S; Sanches M; Corrigan P
    BMJ Open; 2017 Nov; 7(11):e017044. PubMed ID: 29162572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of public stigma scales on alcohol use disorder and substance use disorder.
    Atlam D; Kaylı DŞ; Durusoy R
    J Ethn Subst Abuse; 2023 Sep; ():1-18. PubMed ID: 37665219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.